Canaccord Genuity Maintains Buy on Blend Labs, Lowers Price Target to $4.5

Benzinga Newsdesk www.benzinga.com Negative 63.4%

Neg 63.4% Neu 0% Pos 0%

Canaccord Genuity analyst Joseph Vafi maintains Blend Labs (NYSE:BLND) with a Buy and lowers the price target from $5.25 to $4.5.